Kawasaki Disease in the Time of COVID-19 and MIS-C: The International Kawasaki Disease Registry Journal Articles uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Identity
  •  
  • Additional Document Info
  •  
  • View All
  •  

abstract

  • BACKGROUND: Patients with multisystem inflammatory syndrome in children (MIS-C) and Kawasaki disease (KD) have overlapping clinical features. We compared demographics, clinical presentation, management, and outcomes of patients according to evidence of previous SARS-CoV-2 infection. METHODS: The International Kawasaki Disease Registry (IKDR) enrolled KD and MIS-C patients from sites in North, Central, and South America, Europe, Asia, and the Middle East. Evidence of previous infection was defined as: Positive (household contact or positive polymerase chain reaction [PCR]/serology), Possible (suggestive clinical features of MIS-C and/or KD with negative PCR or serology but not both), Negative (negative PCR and serology and no known exposure), and Unknown (incomplete testing and no known exposure). RESULTS: Of 2345 enrolled patients SARS-CoV-2 status was Positive for 1541 (66%) patients, Possible for 89 (4%), Negative for 404 (17%) and Unknown for 311 (13%). Clinical outcomes varied significantly among the groups, with more patients in the Positive/Possible groups presenting with shock, having admission to intensive care, receiving inotropic support, and having longer hospital stays. Regarding cardiac abnormalities, patients in the Positive/Possible groups had a higher prevalence of left ventricular dysfunction, and patients in the Negative and Unknown groups had more severe coronary artery abnormalities. CONCLUSIONS: There appears to be a spectrum of clinical features from MIS-C to KD with a great deal of heterogeneity, and one primary differentiating factor is evidence for previous acute SARS-CoV-2 infection/exposure. SARS-CoV-2 Positive/Possible patients had more severe presentations and required more intensive management, with a greater likelihood of ventricular dysfunction but less severe coronary artery adverse outcomes, in keeping with MIS-C.

authors

  • Harahsheh, Ashraf S
  • Shah, Samay
  • Dallaire, Frederic
  • Manlhiot, Cedric
  • Khoury, Michael
  • Lee, Simon
  • Fabi, Marianna
  • Mauriello, Daniel
  • Tierney, Elif Seda Selamet
  • Sabati, Arash A
  • Dionne, Audrey
  • Dahdah, Nagib
  • Choueiter, Nadine
  • Thacker, Deepika
  • Giglia, Therese M
  • Truong, Dongngan T
  • Jain, Supriya
  • Portman, Michael
  • Orr, William B
  • Harris, Tyler H
  • Szmuszkovicz, Jacqueline R
  • Farid, Pedrom
  • McCrindle, Brian W
  • Alsalehi, Mahmoud
  • Ballweg, Jean A
  • Barnes, Benjamin
  • Braunlin, Elizabeth
  • Buffone, Ashley
  • Bustamante-Ogando, Juan Carlos
  • Chang, Arthur J
  • Corral, Nicolas
  • Dancey, Paul
  • El-Ganzoury, Mona
  • El-Samman, Nora
  • Elias, Matthew
  • Fernandez-Cooke, Elisa
  • Friedman, Kevin
  • Garrido-Garcia, Luis Martin
  • Garrido, Luis Martin
  • Goldenberg, Guillermo Larios
  • Grcic, Michelle M
  • Harris, Kevin C
  • Hicar, Mark D
  • Hindt, Bridgette
  • Jone, Pei-Ni
  • Kajimoto, Hidemi
  • Kaneta, Kelli
  • Khare, Manaswitha
  • Knutson, Stacie
  • Kutty, Shelby
  • Lanari, Marcello
  • Maksymiuk, Victoria
  • McHugh, Kimberly E
  • Merves, Shae
  • Misra, Nilanjana
  • Mohandas, Sindhu
  • Mondal, Tapas
  • Norozi, Kambiz
  • Nowlen, Todd
  • Pagano, Joseph J
  • Prasad, Deepa
  • Raghuveer, Geetha
  • Ravi, Prasad
  • Sundaram, Balasubramanian
  • Sehgal, Anupam
  • Shah, Ashish
  • Vázquez, Belén Toral
  • Tremoulet, Adriana H
  • Venkataraman, Aishwarya
  • Watelle, Laurence
  • Yamazaki-Naksahimada, Marco Antonio
  • Yetman, Anji T

publication date

  • January 2024